Anthropic brings Claude into healthcare with HIPAA-focused tools

Anthropic unveiled Claude for Healthcare at the J.P. Morgan Healthcare Conference, presenting HIPAA-aligned features and integrations with medical data; the announcement follows OpenAI's recent ChatGPT Health launch.

Anthropic announced Claude for Healthcare, a suite of AI capabilities intended for patients, clinicians and life sciences teams. The announcement coincided with the J.P. Morgan Healthcare Conference in San Francisco. Anthropic says the tools are designed to comply with U.S. medical privacy rules such as HIPAA and to connect with trusted clinical and scientific data sources. The offering is available through updated Claude Pro and Claude Max subscriptions and includes integrations with personal health data systems. Key details: - Launched at the J.P. Morgan Healthcare Conference and positioned for regulated clinical environments. - Built to be HIPAA-aligned and able to tap into healthcare and scientific databases to interpret complex medical information. - Includes life sciences workflow features for clinical trial planning, regulatory document support and biomedical literature review. - Accessible via Claude Pro and Claude Max subscriptions, with integrations to personal health data systems such as Apple Health and fitness apps. - Anthropic emphasizes privacy through its constitutional AI framework; conversations are not used for training by default and enterprise data is locked down. - The announcement follows OpenAI's recent launch of ChatGPT Health, underscoring competition between major AI labs. Summary: Anthropic's move underscores growing interest from major AI labs in deploying generative models in healthcare and research settings and could accelerate integration of these tools into clinical and life sciences workflows. The development raises questions about data privacy, regulatory compliance and clinical accuracy that will influence adoption. Undetermined at this time.